SYBOPHAR

Active Risk: not assessed

Private limited company (pre-2019)founded 2009active for 17 yearsG. E. Lebonlaan 86, 1160 Oudergem, BelgiumKBO/BCE: BE 0815.844.234

Summary

SYBOPHAR is a financial institution. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €343,503 and a net result of €21,720. Equity has been growing by about 8.3% per year since 2018. Its solvency ranks better than 59% of 6,692 sector peers (NACE 64, financial year 2025). The company has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

SYBOPHARActive

Risk analysis Report Compare

Official details

Source: KBO

Status: Active since 26-06-2009 Normal situation
Activity: Activities of holding companies NACE 64210and 2 others
Joint committee: 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit: 2.179.184.083 1160 Oudergem, since 26-06-2009
Financial year end: 31 December
Peppol: Reachable since 11-12-2025

Company details

Board and ownership

Board

TAIROU FATIMA BINTOUDirector · since 25-06-2009

Holdings: Shares in 1 company LES ILES D'OR

Board & ownership

Financial position

Financial institution: outside the modelBankruptcy probability: sector outside the model

Annual accounts 2025

Profit: €21,720; ▲ 31.9%
Equity: €343,503; ▲ 6.7%
Total assets: €569,233; ▲ 3.2%

Financials

SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model

Model not applicable to financial institutions

The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.

neutral

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

16 days early

2024

29 days early

2023

26 days early

2022

25 days early

2021

31 days late

2020

29 days early

2019

32 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 18 days before the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (4 of the last 5 accounts filed within 30 days either side of that date).

Companies Code · seven months

Where today falls in the filing period

03-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Key points

Positive: 8 profitable years in a rowprofit 2025: €21,720 8 years View
Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

08-07-2009 · Gazette deed Incorporation

All 14 events

Comparable companies

These companies have the same main activity as SYBOPHAR: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €471,000 and €611,000, founded between 2008 and 2010.

Company	Total assets	Gross margin
SYBOPHAR Oudergem	€569,233	€27,745
CYBELLE SENSE OF LIVING Genk	€558,653	€26,757
ImprovementatWork Brasschaat	€610,977	€26,504
NELLEN INVEST Waregem	€543,432	€25,654
Check Twice Gent	€509,169	€28,069
ST CONSULT Boutersem	€470,744	€26,369
D.B. PROJECTS Roeselare	€547,789	€23,430

Full comparison

Key facts about SYBOPHAR

What is the company number of SYBOPHAR?: The company number of SYBOPHAR is 0815.844.234. The VAT number is the same number with BE in front: BE 0815.844.234.
Where is SYBOPHAR based?: The registered office is at G. E. Lebonlaan 86, 1160 Oudergem.Company details
What does SYBOPHAR do?: According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of SYBOPHAR?: The legal form of SYBOPHAR is Private limited company (pre-2019) (BVBA).
When was SYBOPHAR founded?: SYBOPHAR was founded on 26-06-2009.
Is SYBOPHAR still active?: Yes, SYBOPHAR is an active enterprise in the KBO register.
Which joint committee does SYBOPHAR fall under?: In its 2025 annual accounts, SYBOPHAR states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of SYBOPHAR?: The turnover in financial year 2025 is ≈ €99,000. This figure is estimated from the gross margin of €27,745 and 1,225 comparable companies of the same size. It probably lies between €53,000 and €190,000. It is a rough estimate.Financials
Is SYBOPHAR profitable?: In financial year 2025, SYBOPHAR made a profit of €21,720.
Where can I find the annual accounts of SYBOPHAR?: SYBOPHAR filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SYBOPHAR due?: SYBOPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline